UBS maintains ArcBest at Neutral, lowers price target to $146 from $154

UBS kept its Neutral rating on ArcBest but reduced its price target to $146 from $154, a 5.2% decrease. This implies a 9.3% upside from the Nov 5 close of $133.59. Recent analyst targets for ArcBest range from $146 to $175.

Original reporting
Published Nov 6, 2026, 1:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 1:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UBS maintains ArcBest at Neutral, lowers price target to $146 from $154 — source image
Decision brief

The 30-second read

$ARCBBearishMed
01

Why it matters

The UBS target reduction signals a more cautious outlook, potentially prompting short-term sell-offs.

02

Market read

A fresh analyst downgrade on ARCB could affect its near-term price trajectory and sector sentiment.

03

What to watch

Potential upside from upcoming contract wins or cost improvements not yet reflected in the target.

Relevance 5/10Novelty 5/10Timing: immediate today

Background

ArcBest (ARCB) is a logistics and transportation services provider. Analyst coverage influences investor perception.

Company-level read

Ticker impact

$ARCBBearishHigh confidence
Context

UBS lowered its price target on ArcBest to $146 from $154, a new analyst downgrade.

Expected impact

likely downside pressure as investors price in the lower target.

Evidence & confidence

Analyst target reductions are a direct catalyst that often precede short-term price declines.

Market effects

May weigh on the transportation/logistics sector as peers could face similar scrutiny.

Limited to U.S. markets where ArcBest trades.

Low global impact; primarily a single-stock analyst update.

Counterpoint

Some investors may view the target cut as an overreaction and look for a buying opportunity at the lower price.

Key entities

  • UBS

    Investment bank providing the revised price target.

  • ArcBest

    Logistics and transportation services firm.

Related articles

$ARCBMed

ArcBest Corp (ARCB) Q3 2026 Earnings Call Highlights: Revenue Jumps 15% as Pricing

ArcBest Corp (ARCB) reported a 15% revenue increase in Q3 2026, driven by pricing discipline and dynamic quoting. CEO Seth Runzer expects weight-per-shipment growth to moderate in Q4. The company anticipates $30M in Asset Light operating income for 2026 and continued growth in 2027. Fuel surcharges offset rising costs, and the company remains confident in its long-term strategy and 2028 targets.

$ARCBMed

ArcBest reports Q3 tonnage gains

ArcBest reported a 9.6% increase in Q3 tonnage per day in its asset-based segment, driven by heavier freight and a shift in freight profile. CEO Seth Runser noted encouraging activity in several sectors. Q3 asset-based operating income rose from $70.2M to $75.6M. The company is being more selective with freight, leading to a 5.1% average increase in contract renewals. ArcBest's tonnage gains outpaced some peers, with Saia reporting a similar increase.

$ARCBMedAI 9/10

ArcBest (ARCB) Q3 2026 Earnings Call Transcript

ArcBest (ARCB) reported Q3 2026 revenue of $1.2B, up 15% YoY, with non-GAAP operating income at $85M. Asset-Based revenue rose 10% YoY, driven by higher weight per shipment and disciplined pricing. Asset-Light saw a $13M YoY profit improvement. Contract renewals averaged 5.1% increases. The company highlighted AI-driven initiatives and awards for service quality.